EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Insights from incorporating quantum computing into drug design workflows

Bayo Lau, Prashant S Emani, Jackson Chapman, Lijing Yao, Tarsus Lam, Paul Merrill, Jonathan Warrell, Mark B Gerstein, Hugo Y K Lam iD

Bioinformatics · 2023

DOI: 10.1093/bioinformatics/btac789 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioinformatics, 2023. Verfasst von Bayo Lau und 8 weiteren Autor:innen. Beteiligte Einrichtung: HypaHealth, HypaHub Inc., San Jose, CA 95128, USA. Hauptthemen laut MEDLINE: Software, COVID-19. Die Arbeit wurde bisher 48-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIMH NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Motivation While many quantum computing (QC) methods promise theoretical advantages over classical counterparts, quantum hardware remains limited. Exploiting near-term QC in computer-aided drug design (CADD) thus requires judicious partitioning between classical and quantum calculations. Results We present HypaCADD, a hybrid classical-quantum workflow for finding ligands binding to proteins, while accounting for genetic mutations. We explicitly identify modules of our drug-design workflow currently amenable to replacement by QC: non-intuitively, we identify the mutation-impact predictor as the best candidate. HypaCADD thus combines classical docking and molecular dynamics with quantum machine learning (QML) to infer the impact of mutations. We present a case study with the coronavirus (SARS-CoV-2) protease and associated mutants. We map a classical machine-learning module onto QC, using a neural network constructed from qubit-rotation gates. We have implemented this in simulation and on two commercial quantum computers. We find that the QML models can perform on par with, if not better than, classical baselines. In summary, HypaCADD offers a successful strategy for leveraging QC for CADD. Availability and implementation Jupyter Notebooks with Python code are freely available for academic use on GitHub: https://www.github.com/hypahub/hypacadd_notebook. Supplementary information Supplementary data are available at Bioinformatics online.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SoftwareCOVID-19HumansWorkflowComputing MethodologiesQuantum TheorySARS-CoV-2Drug DesignMolecular Dynamics Simulation

Autor:innen und Institutionen

  • HypaHealth, HypaHub Inc., San Jose, CA 95128, USA.
  • Program in Computational Biology and Bioinformatics, Yale University, New Haven, CT 06520, USA.
  • Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT 06520, USA.
  • Department of Computer Science, Yale University, New Haven, CT 06520, USA.
  • Department of Statistics & Data Science, Yale University, New Haven, CT 06520, USA.

ORCID-Profile: Hugo Y K Lam

Förderung

  • NIMH NIH HHS
  • National Institutes of Health

Zitieren

APA

Lau, B., Emani, P. S., Chapman, J., Yao, L., Lam, T., Merrill, P., Warrell, J., Gerstein, M. B., & Lam, H. Y. K. (2023). Insights from incorporating quantum computing into drug design workflows. Bioinformatics. https://doi.org/10.1093/bioinformatics/btac789

Vancouver

Lau B, Emani PS, Chapman J, Yao L, Lam T, Merrill P, et al. Insights from incorporating quantum computing into drug design workflows. Bioinformatics. 2023. doi:10.1093/bioinformatics/btac789

BibTeX
@article{Lau2023,
  author = {Lau, Bayo and Emani, Prashant S and Chapman, Jackson and Yao, Lijing and Lam, Tarsus and Merrill, Paul and Warrell, Jonathan and Gerstein, Mark B and Lam, Hugo Y K},
  title = {Insights from incorporating quantum computing into drug design workflows},
  journal = {Bioinformatics},
  year = {2023},
  doi = {10.1093/bioinformatics/btac789}
}
Kostenlos starten →